{"result": "Here is a comprehensive summary of the data:\n\nHER2+ IBC (Human Epidermal Growth Factor Receptor 2-positive Invasive Breast Cancer) is a subtype of Invasive Breast Cancer (IBC) that has been found to have the longest median Overall Survival (OS) after brain metastasis and is related to the anti-HER2 therapy era. This subtype is typically treated with pertuzumab plus trastuzumab as a standard neoadjuvant treatment. HER2+ IBC is a type of breast cancer that is positive for the human epidermal growth factor receptor 2 (HER2) protein and is treated with dual anti-HER2 antibodies and anthracycline-containing regimens.\n\nNote: I resolved the contradictions by combining the information from each description to provide a comprehensive summary. I also used third-person language and included the entity names for clarity.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"HER2+ IBC\\\"\"\nDescription List: [\"\\\"HER2+ IBC is a subtype of IBC that has been found to have the longest median OS after brain metastasis and is related to the anti-HER2 therapy era.\\\"\", \"\\\"HER2+ IBC is a subtype of IBC that is treated with pertuzumab plus trastuzumab as a standard neoadjuvant treatment.\\\"\", \"\\\"HER2+ IBC is a type of breast cancer mentioned in the studies.\\\"\", \"\\\"HER2+ IBC is a type of breast cancer that is treated with dual anti-HER2 antibodies and anthracycline-containing regimens.\\\"\", \"\\\"HER2+ IBC refers to a subtype of breast cancer that is positive for the human epidermal growth factor receptor 2 (HER2) protein.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}